Chemical Abstracts, vol. 105, No. 17, Oct. 27, 1986, Columbus, OH, abstract No. 148687, V. Siksnis et al., "Stabilization of Enzymes by their Chemical Modification with Cyclic Aromatic Acid Anhydrides", Dokl. Akad. Nauk. SSSR, vol. 288, No. 6, 1986 (1508-1512). |
Chemical Abstracts, vol. 103, No. 23, Dec. 9, 1985, Columbus, OH, abstract No. 192648, R.J.M. Parker & R.S. Hodges, "Photoaffinity Probes Provide a General Method to Prepare Peptide Conjugates from Native Protein Fragments", J. Prot. Chem., vol. 3, No. 5-6, 1984 (479-489). |
Swart, P.J. and Meijer, D.K.F., International Antiviral News, "Negatively-Charged Albumins: A Novel Class of Polyanionic Proteins with a Potent Anti-HIV Activity", vol. 2, No. 5, Longmun Group Ltd., 69-71 (1994). |
Harmsen, M.C., Swart, P.J., de Bethune, M.P., Pauwels, R., De Clercq, E., The, T.H. & Meijer, D.K.F., "Antiviral effects of plasma and milk proteins: Lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro", The Journal of Infectious Diseases, 172, 380-388 (1995). |
Gordon, L.M., Waring, A.J., Curtain, C.C., Kirkpatrick, A., Leung, C., Faull, K. & Mobley, P.W., "Antivirals that target the amino-terminal domain of HIV type 1 glycoprotein 41", Aids Research and Human Retroviruses 11, 6, 677-686 (1995). |
Scofield et al, "Binding of Sperm to Somatic Cells Via HLA-DR Modulation by Sulfated Carbohydrates.sup.1 ", vol. 148, pp. 1718-1724, No. 6, (1992), The Journal of Immunology. |
Phillips et al, "An Assay for HIV Infection of Cultured Human Cervix-Derived Cells", vol. 52, pp. 1-13 (1995), Journal of Virological Methods. |
Ashida et al, "Lymphocyte Major Histocompatibility Complex-Encoded Class II Structures May Act as Sperm Receptors", vol. 84, pp. 3395-3399, (1987), Immunology. |
Lundblad, R.L., Chemical Reagents for Protein Modification, 2nd Edition, CRC Press, Chapter 10, "The Modification of Lysine", 129-171 (1991). |
Suzuki, T., Burlingame, R.W., Cavalot, F., Andres, G., Kashiwazaki, S. and Tan, E.M., "Antibodies in Rabbits Immunized with Cationized IgG React with Histones H3 and H4", Arthritis and Rheumatism, 35, 1218-1226 (1992). |
Muckerheide, A., Apple, R.J., Pesce, A.J. and Michael, J.G., "Cationization of Protein Antigens", "I. Alteration of Immunogenic Properties", The Journal of Immunology, 138, 833-837 (1987). |
Neurath, A. R., Strick, N., Haberfield, P., and Jiang, S., (1992), "Rapid Prescreening for Antiviral Agents Against HIV-1 Based on their Inhibitory Activity in Site-directed Immunoassays. II. Prophyrins Reacting with the V3 loop of gp120", Antiviral Chem. Chemother., 3, 55-63. |
Neurath, A. R., Haberfield, P., Joshi, B., Hewlett, I. K., Strick, N., and Jiang, S., (1991), "Rapid Prescreening for Antiviral Agents Against HIV-1 Based on their Inhibitory Activity in Site-directed Immunoassays I. The V3 loop of gp120 as Target", Antiviral Chem. Chemother., 2, 303-312. |
Neurath, A.R. and Strick, N., (1980), "Antibodies as Immunological Probes for Studying the Denaturation of HBsAg", J. Med. Virol. 6, 309-322. |
Jansen et al, R. W., Schols, D., Pauwels, R., DeClercq, E. and Meijer, D.K.F., "Novel Negatively Charged, Human Serum Albumins Display Potent and Selective in Vito Anti-Human Immunodeficiency Virus Type 1 Activity", 1993, vol. 44, pp. 1003-1007, Molecular Pharmacology. |
Asim Kumar Debnath, Shibo Jiang, Nathan Strick, Kang Lin, Paul Haberfield and A. Robert Neurath, (1994), "Three-Dimensional Structure-Activity Analysis of a Series of Porphyrin Derivatives with Anti-HIV-1 Activity Targeted to the V3 Loop of the gp120 Envelope Glycoprotein of the Human Immunodeficiency Virus Type 1", J. Med. Chem., 37, 1099-1108. |
Neurath, A. R., Strick, N., Lin, K., Debnath, A. K., and Jiang, S. (1994), "Tin protoporphyrin IX Used in Control of Heme Metabolism in Humans Effectively Inhibits HIV-1 Infection", Antiviral Chem. Chemother., 5, 322-330. |
Jiang, S. and Neurath, A.R., (1992), "Potential Risks of Eliciting Antibodies Enhancing HIV-1 Infection of Monocytic Cells by Vaccination with V3 loops of Unmatched HIV-1 Isolates", AIDS, 6, 331-342). |
Jiang, S., Lin, K., and Neurath, A.R., (1991), "Enhancement of Human Immunodeficiency Virus Type 1 Infection by Antisera to Peptides from the Envelope Glycoproteins gp120/gp41", J. Exp. Med., 174, 1557-1563. |
Fomsgaard, A., Hirsch, V.M., and Johnson, P.R., (1992), "Cloning and Sequences of Primate CD4 molecules: Diversity of the Cellular Receptor for Simian Immunodeficiency Virus/Human Immunodeficiency Virus", Eur. J. Immunol., 22, 2973-2981. |
Freed, E.O., Myers, D.J., and Risser, R., (1990), "Characterization of the Fusion Domain of the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein gp41", Proc Natl Acad Sci USA, 87, 4650-4654. |
Healey, D., Dianda, L., Moore, J.P., McDougal, J.S., Moore, M.J., Estess, P., Buck, D., Kwong, P.D., Beverley, P.C.L., and Sattentau, Q.J., (1990), "Novel anti-CD4 Monoclonal Antibodies Separate Human Immunodeficiency Virus Infection and Fusion of CD4.sup.+ Cells From Virus Binding", J. Exp. Med., 172, 1233-1242. |
Jansen, R.W., Molema, G., Pauwels, R., Schols, D., DeClercq, E. and Meijer, D.K.F., "Potent In Vitro Anti-Human Immunodeficiency Virus-1 Activity of Modified Human Serum Albumins", Molecular Pharmacology, 39, 818-823 (1991). |
Marcon, L. and Sodroski. J. (1994), "gp120-Independent Fusion Mediated by the Human Immunodeficiency Virus Type 1 gp41 Envelope Glycoprotein: A Reassessment", J. Virol., 68, 1977-1982. |
McKenzie, H.A., (1971), "Whole casein: Isolation, Properties, and Zone Electrophoresis", In: Milk Proteins Chemistry and Molecular Biology, vol. II., H.A. McKenzie (ed.), pp. 87-116. Academic Press, New York. |
Moore, J.P., (1993), "A Monoclonal Antibody to the CDR-3 Region of CD4 Inhibits Soluble CD4 Binding to Virions of Human Immunodeficiency Virus Type 1", J. Virol., 67, 3656-3659. |
Ostresh, J.M., Husar, G.M., Blondelle, S.E., Dorner, B., Weber, P.A., and Houghten, R.A., (1994), "Libraries from libraries: Chemical Transformation of Combinatorial Libraries to Extend the Range and Repertoire of Chemical Diversity," Proc. Natl. Acad. Sci. USA, 91, 11138-11142. |
Ryu, S.-E., Truneh, A., Sweet, R.W., and Hendrickson, W.A., (1994), "Structures of an HIV and MHC Binding Fragment from Human CD4 as Refined in Two Crystal Lattices", Structure, 2, 59-74. |
Parish, C.R., Low, L., Warren, H.S., and Cunningham, A.L., (1990), "A Polyanion Binding Site on the CD4 molecule. Proximity to the HIV-gp120 Binding Region," J. Immunol., 145, 1188-1195. |
Siegel, F., Kurth, R., and Norley, S., (1995), "Neither Whole Inactivated Virus Immunogen nor Passive Immunoglobulin Transfer Protects Against SIV.sub.agm Infection in the African Green Monkey Natural Host", J. AIDS, 8, 217-226. |
Takami, M., Sone, T., Mizumoto, K., Kino, K., and Tsunoo, H. (1992), "Maleylated Human Serum Albumin Inhibits HIV-1 infection in Vitro", Biochem. Biophys. Acta., 1180, 180-186. |
Watanabe, M., Levine, C.G., Shen, L., Fisher, R.A., and Letvin, N.L. (1991), "Immunization of Simian Immunodeficiency Virus-Infected Rhesus Monkeys with Soluble Human CD4 Elicits and Antiviral Response," Proc. Natl. Acad. Sci. USA, 88, 4616-4620. |
Watanabe, M., Chen, Z.W., Tsubota, H., Lord, C.I., Levine, C.G. and Letvin, N.L., (1991), "Soluble Human CD4 Elicits an Antibody Response in Rhesus Monkeys that Inhibits Simian Immunodeficiency Virus Replication", Proc. Natl. Acad. Sci. USA, 88, 120-124. |
Watanabe, M., Boyson, J.E., Lord, C.I., and Letvin, N.L., (1992), "Chimpanzees Immunized with Recombinant Soluble CD4 Develop Anti-self CD4 Antibody Responses with Anti-human Immunodeficiency Virus Activity", Proc. Natl. Acad. Sci. USA, 89, 5103-5107. |
Wilks, D., Walker, L., O'Brien, J., Habeshaw, J., and Dalgleish, A., (1990), "Differences in Affinity of Anti-CD4 Monoclonal Antibodies Predict their Effects on Syncytium Induction by Human Immunodeficiency Virus", Immunol., 71, 10-15. |
Peterson, A. and Seed, B., (1988), "Genetic Analysis of Monoclonal Antibody and HIV Binding Sites on the Human Lymphocyte Antigen CD4", Cell, 54, 65-72. |
Sattentau, Q.J., Arthos, J., Deen, K., Hanna, N., Healey, D., Beverley, P.C.L., Sweet, R., and Truneh, A., (1989), "Structural Analysis of the Human Immunodeficiency Virus-binding Domain of CD4", J. Exp. Med., 170, 1319-1334. |
Houlgatte, R., Scarmato, P., El Marhomy, S., Martin, M., Ostankovitch, M., Lafosse, S., Vervisch, A., Auffray, C., and Platier-Tonneau, D., (1994), "HLA class II Antigens and the HIV Envelope Glycoprotein gp120 Bind to the Same Face of CD4", J. Immunol., 152, 4475-4488. |
Camerini, D. and Seed, B., (1990), "A CD4 Domain Important for HIV-Mediated Syncytium Formation Lies Outside the Virus Binding Site", Cell, 60, 747-754. |
Nicholls, A., Sharp, K., and Honig, B. (1991), "Protein Folding and Association: Insights from the Interfacial and Thermodynamic Properties of Hydrocarbons," Proteins, 11, 281-296. |
Bernstein, F.C., Koetz, T.F., Williams, G.J.B., Meyer, E.F., Jr., Brice, M.D., Rodgers, J.R., Kennard, O., Shimanouchi, T., Tasumi, M., (1977), "The Protein Data Bank: A computer-based Archival File for Macromolecular Structure", J. Mol. Biol., 112, 535-542. |
Lundblad, R. C., (1991), Chemical Reagents For Protein Modification, CRC Press, Boca Raton, Florida. |
In: Methods in Enzymology., vol. 92. Immunochemical Techniques, Langone, J.J. and Van Vunakis, H. (eds.), pp. 577-588, Academic Press, New York. |
Modern Approaches to New Vaccines Including Prevention of AIDS, H.S. Ginsberg, F. Brown, R.M. Chanock, and R.A. Lerner (eds.), pp. 203-208, Cold Spring Harbor Laboratory Press, New York. |
Abraham, R., Singh, N., Mukhopadhyay, A., Basu, S.K., Bal, V., and Rath, S., (1994), "Modulation of Immunogenicity and Antigenicity of Proteins by Maleylation to Target Scavenger Receptors on Macrophages," J. Immunol., 154, 1-8. |
George, D.G., Barker, W.C., Mewes, H.-W., Pfeiffer, F., and Tsugita, A., (1994), "The PIR-International Protein Sequence Database", Nucl. Acids Res., 22, 3569-3573. |
Lederman, S., Gulick, R., and Chess, L., (1989), "Dextran Sulfate and Heparin Interact with CD4 Molecules to Inhibit the Binding of Coat Protein (gp120) of HIV", J. Immunol., 143, 1149-1154. |
Yahi, N., Sabatier, J.-M., Baghdiguian, S., Gonzalez-Scarano, F. and Fantini, J., "Synthetic Multimeric Peptides Derived from the Principal Neutralization Domain (V3 loop) of Human Immunodeficiency Virus Type 1 (HIV-1) gp120 Bind to Galactosylceramide and Block HIV-1 Infection in a Human CD4-negative Mucosal Epithelial Cell Line", J. Virol., 69, 320-325 (1995). |
Lo, T.W.C., Westwood, M.E., McLellan, A.C., Selwood, T. and Thornalley, P.J., "Binding and Modification of Proteins by Methylglyoxal Under Physiological Conditions. A kinetic and Mechanistic Study with N.alpha.-Acetylarginine, N.alpha.-Acetylcysteine, and N.alpha.-Acetyllysine, and Bovine serum albumin", (1994), J. Biol. Chem., 269, 32299-32305. |
Westwood, M.E., McLellan, A.C., and Thornalley, P.J., (1994), "Receptor-mediated Endocytic Uptake of Methylglyoxal-modified Serum Albumin. Competition with Advanced Glycation End Product-modified Serum Albumin at the Advanced Glycation End Product Receptor", J. Biol. Chem., 269, 32293-32298. |
Yahi, N., Baghdiguian, S., Moreau, H. and Fantini, J., "Galactosyl Ceramide (or a Closely Related Molecule) is the Receptor for Human Immunodeficiency Virus Type 1 on Human Colon Epithelial HT29 Cells", J. Virol., 66, 4848-4854 (1992). |
Yahi, N. et al., "Suramin Inhibits Binding of the V3 Region of HIV-1 Envelope Glycoprotein gp120 to Galactosylceramide, the Receptor for HIV-1 gp 120 on Human Colon Epithelial Cells", J. Biol. Chem. 269, 24349-24353 (1994). |
Long, D., Berson, J.F., Cook, D.G. and Doms, R.W., "Characterization of Human Immunodeficiency Virus Type 1 gp120 Binding to Liposomes Containing Galactosylceramide", J. Virol., 68, 5890-5898 (1994). |
Furuta, Y. et al., "Infection of Vaginal and Colonic Epithelial Cells by the Human Immunodeficiency Virus Type 1 is Neutralized by Antibodies Raised Against Conserved Epitopes in the Envelope Glycoprotein gp120", Proc. Natl. Acad. Sci U.S.A., 91, 12559-12563 (1994). |
Fantini, J., Cook, D.G., Nathanson, N., Spitalnik, S.L. and Gonzalez-Scarano, F., "Infection of Colonic Epithelial Cell Lines by Type 1 Human Immunodeficiency Virus is Associated with Cell Surface Expression of Galactosylceramide, a Potential Alternative gp120 Receptor", Proc. Natl. Aca. Sci. U.S.A., 90, 2700-2704 (1993). |
Cook, D.G., Fantini, J., Spitalnik, S.L. and Gonzalez-Scarano, F., "Binding of Human Immunodeficiency Virus Type 1 (HIV-1) gp120 to Galactosylceramide (GalCer): Relationship to the V3 Loop", Virology, 201, 206-214 (1994). |
Webster II University Dictionary Defining "Plasma", (1988). |
Delgado, "Uses & Properties of Peg-Linked Proteins" Embase 92348412, (1992). |
"Advances in Food & Nutrition Research" #33 John Kinsella, Academic Press, (1989). |
Baruchel et al, "Anti-HIV Activity of Whey Protein" AIDS Conf., Yokohama, (Aug. 7, 1994) p. 404. |